Therapeutic Vaccination for HPV-Mediated Cancers

Area of Science:

• Oncology
• Immunology
• Vaccinology

Background:

• Human papillomavirus (HPV) is a major cause of various cancers.
• Therapeutic vaccines aim to eliminate existing tumor cells by stimulating an immune response.
• Current treatment strategies for HPV-mediated malignancies require novel approaches.

Purpose of the Study:

• To review the fundamental concepts of therapeutic vaccines for HPV-mediated cancers.
• To discuss the current efficacy and delivery platforms of therapeutic HPV vaccines.
• To explore future directions and potential combinations for HPV vaccine therapy.

Main Methods:

• This is a narrative review.
• Literature search on therapeutic HPV vaccines and their clinical applications.
• Analysis of randomized controlled trials and ongoing studies.

Main Results:

• Therapeutic HPV vaccines utilize diverse antigen delivery platforms (DNA, RNA, peptides, proteins, vectors, APCs).
• Efficacy is demonstrated in cervical intraepithelial neoplasia.
• Limited efficacy in established HPV-mediated malignancies, but promising results in ongoing trials, especially in combination therapies.

Conclusions:

• Therapeutic HPV vaccines have a strong biological basis for treating HPV-mediated malignancies.
• Combination therapies, including immune checkpoint inhibitors, are anticipated to enhance vaccine effectiveness.
• Further research and clinical trials are crucial for optimizing therapeutic HPV vaccine strategies.